No Data
US Stock MarketDetailed Quotes
MYO Myomo
Watchlist
0.553
+0.017+3.14% Close 05/31 16:00 ET
0.5520.000-0.02%
Post 17:53 ET
0.558High0.515Low119.30KVolume
0.526Open0.536Pre Close64.37KTurnover0.81%Turnover RatioLossP/E (TTM)11.56MMarket Cap2.39052wk HighLossP/E (Static)20.92MShares0.36952wk Low1.20P/B8.17MFloat Cap450.000Historical High--Dividend TTM14.78MShs Float0.369Historical Low--Div YieldTTM7.93%Amplitude0.539Avg Price1Lot Size
Post-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Company
Myomo, Inc. is a medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. It offers MyoPro, an upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury, ALS or other neuromuscular disease or injury. The company was founded by Stephen Kelly, John McBean, Mira Sahney, and Kailas N. Narendran on September 1, 2004 and is headquartered in Boston, MA.
Revenue Breakdown
Business
Unit:USD
NameYOYOperating income%
Direct to patient--10.71M64.72%
Clinical/Medical providers--4.84M29.24%
License revenue--1M6.04%
News
Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2023
UpgradesAccording to Susquehanna, the prior rating for Caesars Entertainment Inc (NASDAQ:CZR) was changed from Negative to Neutral. For the first quarter, Caesars Entertainment had an EPS of $0.63, co
Myomo Initiated at Buy by Maxim Group
Myomo Initiated at Buy by Maxim Group
Myomo Price Target Announced at $2.00/Share by Maxim Group
Myomo Price Target Announced at $2.00/Share by Maxim Group
Comments
Watchlist
$NovaBay Pharmaceuticals(NBY.US$ ER 5/11 AH, 1M order will be in Q2 earnings. beat down stock.
$Myomo(MYO.US$ ER 5/10 AH, 1.7M license revenue.
$Quantum Computing(QUBT.US$ participating in Cyber security event in Minneapolis on May 8-11, might have some positive news, plus ER 5/22 PM
also will add to list:
$Nemaura Medical(NMRD.US$$Sintx Technologies(SINT.US$
$Myomo(MYO.US$ ER 5/10 AH, 1.7M license revenue.
$Quantum Computing(QUBT.US$ participating in Cyber security event in Minneapolis on May 8-11, might have some positive news, plus ER 5/22 PM
also will add to list:
$Nemaura Medical(NMRD.US$$Sintx Technologies(SINT.US$
1
Read more